Optimal costs of HIV pre-exposure prophylaxis for men who have sex with men

Medicine & Life Sciences

• Pre-Exposure Prophylaxis 100%
• Sexual and Gender Minorities 72%
• HIV 48%
• Costs and Cost Analysis 43%
• Drug Costs 38%
• Quality-Adjusted Life Years 28%
• Emtricitabine 9%
• Tenofovir 8%
• Decision Support Techniques 7%
• Organizations 5%
• Accidental Falls 5%
• Health 3%
• Infections 3%

Agriculture & Biology

• disease control 61%
• quality-adjusted life year 49%
• gender 42%
• drugs 23%
• cost estimates 9%
• fumarates 8%
• decision support systems 8%
• cost effectiveness 7%
• mouth 5%
• duration 4%
• infection 3%
• methodology 1%

Chemical Compounds

• Drug 37%
• Tenofovir Disoproxil Fumarate 24%
• Emtricitabine 23%
• Time 5%